ロード中...

Fixed duration vs continuous therapy in multiple myeloma

The introduction of new drugs with less severe toxicity profiles than those of conventional antimyeloma agents allowed the evaluation of continuous therapy compared with fixed duration therapy. In transplant-eligible patients, consolidation therapy with bortezomib or bortezomib-based regimens showed...

詳細記述

保存先:
書誌詳細
出版年:Hematology Am Soc Hematol Educ Program
主要な著者: Ludwig, Heinz, Zojer, Niklas
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142590/
https://ncbi.nlm.nih.gov/pubmed/29222258
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!